Hoey Investments’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.6K Buy
77
+2
+3% +$376 ﹤0.01% 241
2026
Q1
$14.8K Hold
75
﹤0.01% 233
2025
Q4
$13.8K Hold
75
﹤0.01% 235
2025
Q3
$11.5K Buy
75
+50
+200% +$7.57K ﹤0.01% 247
2025
Q2
$3.49K Hold
25
﹤0.01% 306
2025
Q1
$3.67K Hold
25
﹤0.01% 265
2024
Q4
$3.28K Buy
25
+19
+317% +$2.66K ﹤0.01% 270
2024
Q3
$936 Hold
6
﹤0.01% 333
2024
Q2
$936 Buy
+6
New +$903 ﹤0.01% 333

Other funds holding AZN

Hoey Investments's AZN Position: Q2 2026 in Review

Hoey Investments increased its AstraZeneca (AZN) stake by 2.7% in Q2 2026, buying an estimated $376 and bringing the position to 77 shares worth $14.6K. The position accounts for ﹤0.01% of the portfolio, ranked #241.

Hoey Investments first reported a position in AZN in Q2 2024 and has held it in 9 quarters since. The position peaked at $14.8K in Q1 2026. 906 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Hoey Investments held 77 shares of AstraZeneca worth $14.6K as of Q2 2026.
  • Hoey Investments bought 2 AstraZeneca shares in Q2 2026, an estimated $376.
  • AstraZeneca made up ﹤0.01% of Hoey Investments's portfolio in Q2 2026, its #241 holding.
  • Hoey Investments first reported a position in AstraZeneca in Q2 2024 and has held it in 9 quarters since.
  • Hoey Investments's AstraZeneca position peaked at $14.8K in Q1 2026.
  • 906 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Hoey Investments's 13F filing for Q2 2026, filed 27 Jul 2026.